Giordano Christopher Thomas

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 6
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
TENAX THERAPEUTICS, INC.CEOOpen-market buy$8,8374,850 sharesSep 15, 2026TENAX THERAPEUTICS, INC.CEO$8,837Buy · Sep 15Open-market buy4,850Sep 15, 2026
TENAX THERAPEUTICS, INC.CEOOpen-market buy$11,2506,000 sharesSep 15, 2026TENAX THERAPEUTICS, INC.CEO$11,250Buy · Sep 15Open-market buy6,000Sep 15, 2026
TENAX THERAPEUTICS, INC.CEOOption exercisenothing paid8,500 sharesJul 14, 2026TENAX THERAPEUTICS, INC.CEOnothing paidExercise · Jul 14Option exercise8,500Jul 14, 2026
TENAX THERAPEUTICS, INC.CEOOption exercisenothing paid219 sharesJul 14, 2026TENAX THERAPEUTICS, INC.CEOnothing paidExercise · Jul 14Option exercise219Jul 14, 2026
TENAX THERAPEUTICS, INC.CEOOption exercise$50,4908,500 sharesJul 14, 2026TENAX THERAPEUTICS, INC.CEO$50,490Exercise · Jul 14Option exercise8,500Jul 14, 2026